Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘GlaxoSmithKline plc (GSK)’

Ken Fisher FISHER ASSET MANAGEMENT

Billionaire Ken Fisher is Bullish About These Dividend Stocks

Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July......(read more)
Insider Trading Eyeglasses

Hedge Fund and Insider Trading News: Jim Chanos, Ken Griffin, Marc Lasry, York Capital Management, GlaxoSmithKline PLC (GSK), Yelp Inc (YELP), and More

Chanos shorts Envision, Says KKR May Get Cold Feet on Deal (Reuters) NEW YORK (Reuters) – Hedge fund manager Jim Chanos says he is betting that......(read more)
cough, pneumonia, senior, cold, bronchopneumonia, blond, medical, patient, whooping, infection, bronchial, ill, sick, elderly, convulsive, cramps, woman, inflammation,

GlaxoSmithKline Plc (GSK) Shrugs Skeptics Concerns To Launch Cold Flu Tracker App

GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Introduction Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier......(read more)
Emergent Biosolutions Inc (NYSE:EBS)

Investing in Counteracting Biological and Chemical Agents

Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

There is perhaps nothing scarier than a cancer diagnosis. A study in 2010 conducted by Cancer Research UK demonstrated this to the “T,” when......(read more)
Exelixis, Inc. (NASDAQ:EXEL)

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc......(read more)
Monster Beverage Corp (NASDAQ:MNST)

Monster Beverage Corp (MNST), The Coca-Cola Company (KO), PepsiCo, Inc. (PEP): Will These Soft Drink Companies Go Flat?

There’s no question that America is addicted to caffeine and sugar. With some of the highest obesity (35.7%) and diabetes (8.3%) rates in the world......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive......(read more)
Amarin Corporation plc (ADR) (NASDAQ:AMRN)

Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will This Fishy Biotech Go Belly Up?

There are plenty of biotech companies that put all of their eggs in one basket these days. For speculative traders, these stocks can lead to exciting......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors

Looking for the best-performing sector in this year’s big market rally? It may just be the biotech sector, which has erupted with astronomical gains......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they’re hot like summer, sometimes they’re dormant......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?

There hasn’t been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before......(read more)
Mylan Inc. (NASDAQ:MYL)

Mylan Inc. (MYL), GlaxoSmithKline plc (ADR) (GSK), Nationstar Mortgage Holdings Inc (NSM): Three Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): Does ChemoCentryx Inc (CCXI) Have a Platform Problem?

It hasn’t been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI). After announcing at the end of August that......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Stryker Corporation (SYK): 3 Alternative Ways to Invest in China’s Booming Health Care Industry

China has loomed large in health care headlines recently, due to the GlaxoSmithKline plc (ADR) (NYSE:GSK) scandal that erupted in July. Glaxo, which......(read more)
Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains

I cannot emphasize enough how important having a deep and diverse pipeline, as well as numerous potential collaborative partners, can be in the biotechnology......(read more)
Theravance Inc (NASDAQ:THRX)

GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug

Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S. Food and Drug......(read more)
Netflix, Inc. (NASDAQ:NFLX)

Netflix, Inc. (NFLX), Advanced Micro Devices, Inc. (AMD), Mylan Inc. (MYL): Today’s Three Best Stocks

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), China Mobile Ltd. (ADR) (CHL): Will China’s Corporate Crackdown Scare Off Investors?

China’s not losing importance in the eyes of investors, despite the world’s second-largest economy’s slump this year. The country remains......(read more)
Unilever plc (ADR)

Unilever plc (ADR) (UL), GlaxoSmithKline plc (ADR) (GSK), McGraw Hill Financial Inc (MHFI): Emerging Markets, The Show Must Go On!

Emerging-market stocks have been butchered over the past few months amid fears that the Federal Reserve will begin winding down its bond-buying program......(read more)
Theravance Inc (NASDAQ:THRX)

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector

With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for......(read more)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech

With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment

Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (GSK), Merck & Co. Inc. (MRK): HPV Vaccine for Boys Has “Good Start” in 1st Year

ATLANTA (AP) — When the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell. But a new report......(read more)
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail

Drugs fail their clinical trials for all kinds of reasons. Sometimes, it’s related to efficacy; sometimes, it’s safety related. Most of the......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy

In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it. It seems now that Sarepta......(read more)
Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ), AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): The Impact of a Failed Crohn’s Disease Trial Study

A small section of the total Crohn’s Disease) patient population is resistant to standard treatment options. Known as tumor necrosis factor-alpha......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Can This HIV Drug Challenge Gilead Sciences, Inc. (GILD)’s Domination?

ViiV Healthcare — a joint venture by Pfizer Inc. (NYSE:PFE) and GlaxoSmithKline plc (ADR) (NYSE:GSK) formed in 2009 with both companies transferring......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?

There are many undeniable tailwinds the pharmaceutical industry should capitalize on going forward, such as rising health-care costs and the aging U.S......(read more)
Perrigo Company (NYSE:PRGO)

Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN), Johnson & Johnson (JNJ): Is This Health Care Stock Underrated?

Shares of Perrigo Company (NYSE:PRGO), one of the world’s largest health care suppliers, slid with the broader market on Aug. 15 after the company......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?

Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene — the largest gene on the X......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week

While many investors worried about the Nasdaq’s three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn’t have......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): ChemoCentryx Inc (CCXI) Collapses on Crohn’s Disease Results

Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat. The huge sell-off......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK): The Past, Present, and Future of HIV Treatments

HIV, the virus that causes AIDS, has become one of the world’s most devastating diseases since it was first recognized more than three decades ago......(read more)
Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) – CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)

For years, satirical late-night TV host Stephen Colbert has been running a series on his show called “Better Know a District,” which highlights......(read more)
Sarepta Therapeutics Inc

GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?

Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa  for a moment......(read more)
Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc. (OSIR), GlaxoSmithKline plc (ADR) (GSK), Forest Laboratories, Inc. (FRX): This Week in Biotech

With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Jim Chanos on china map

GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): China’s Murky Business Climate Won’t Clear Up Soon

A strong week for investors ended especially well in China, as Hong Kong’s HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week......(read more)
Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ), Express Scripts Holding Company (ESRX), Gilead Sciences, Inc. (GILD): Three Great Buy-and-Hold Health-Care Stocks

This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure

On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc......(read more)
How Slower Growth, Falling Oil Will Boost This Airline

Gannett Co., Inc. (GCI), Mondelez International Inc (MDLZ): Here’s What Berkshire Hathaway Inc. (BRK.B) Sold Last Quarter

It’s that time again, investors! Berkshire Hathaway Inc. (NYSE:BRK.B) just released its latest stock holdings today, and I’ve already spent......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern

GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor

With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor......(read more)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?

Overweight? You can now officially blame it on your parents. Or at least the genes they passed along to you. Quite a few research papers published recently......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Roche Holding Ltd. (ADR) (RHHBY): Why Alex Rodriguez Could Bring Big Business to This Sector

Baseball star Alex Rodriguez had an opportunity to be perhaps the greatest player of the past decade or even longer — that was until he threw it......(read more)
Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On

Note: This article has been amended to better reflect Lemtrada’s market position. Currently existing immunomodulatory drugs that treat Multiple......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Amgen, Inc. (AMGN): The Best-Selling Medications of 2013 (So Far)

Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits......(read more)